Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Total Current Liabilities (2023 - 2025)

Xenetic Biosciences' Total Current Liabilities history spans 6 years, with the latest figure at $968025.0 for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 8.25% year-over-year to $968025.0; the TTM value through Dec 2025 reached $968025.0, up 8.25%, while the annual FY2025 figure was $968025.0, 8.25% up from the prior year.
  • Total Current Liabilities reached $968025.0 in Q4 2025 per XBIO's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q2 2024 to a low of $667927.0 in Q1 2025.
  • Average Total Current Liabilities over 3 years is $955390.4, with a median of $898846.5 recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: soared 82.21% in 2024, then plummeted 43.09% in 2025.
  • A 3-year view of Total Current Liabilities shows it stood at $809585.0 in 2023, then grew by 10.46% to $894263.0 in 2024, then increased by 8.25% to $968025.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Total Current Liabilities are $968025.0 (Q4 2025), $1.1 million (Q3 2025), and $903430.0 (Q2 2025).